Surgery-A challenge in haemophiliacs with inhibitors

Hamostaseologie

Volumn 29, Issue SUPPL1, 2009, Pages

  Serban, Margit ^a   Poenaru, D ^a   Pop, L ^a   Ionita, H ^a   Mihailov, D ^a   Tepeneu, N ^a   Badeti, R ^a   Lighezan, D ^a   Schramm, W ^b  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Haemophilia; Inhibitors; Surgery

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; COAGULATING AGENT; PROTHROMBIN COMPLEX CONCENTRATES; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; ECONOMICS; ERYTHROCYTE TRANSFUSION; HEALTH CARE COST; HEMOPHILIA A; HUMAN; POSTOPERATIVE HEMORRHAGE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; ROMANIA; SURGERY; TREATMENT OUTCOME; VON WILLEBRAND DISEASE;

ADOLESCENT; ADULT; BLOOD COAGULATION FACTORS; CHILD; CHILD, PRESCHOOL; COAGULANTS; ERYTHROCYTE TRANSFUSION; FACTOR VIIA; FACTOR VIII; HEALTH CARE COSTS; HEMOPHILIA A; HUMANS; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; ROMANIA; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME; VON WILLEBRAND DISEASES; YOUNG ADULT;

EID: 75549086996     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1617199     Document Type: Article

References (6)

1. Goudemand J. Treatment of patients with inhibitors: cost issues. Haemophilia 1999; 5: 397-401.
2. Schramm W, Serban M. Hemostazeologie clinica. Timisoara: Ed. Brumar 2001, 324-325.
3. Rodriguez-Merchan EC, Rocino A, Ewenstein B et al. Consensus perspectives on surgery in hemophilia patients with inhibitors: Summary statement. Hemophilia 2004; 10 (Suppl 2): 50-52.
4. Mihailov D, Serban M, Badeti R et al. Economic evaluation of orthopedic and surgical interventions in hemophiliacs - not only direct medical costs matter. 36th Hemophilia Symposium Hamburg 2005. Scharrer I, Schramm W. Heidelberg: Springer 2007; 161-167.
5. Negrier C, Fleury R, Hoots KW et al. The use of FEIBA during surgeries in haemophilia patients with inhibitors to factor VIII or IX. The XXI Congress of the International Society of Thrombosis and Haemostasis Geneva, Switzerland, July 6-12, 2007.
6. Obergfell A, Auvinen MK, Mathew P. Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature. Haemophilia 2008; 14: 233-241.